PHARMADRIES

Active

Public limited companyfounded 200718 yrs activeElandstraat 58, 1170 Watermaal-Bosvoorde, BelgiumKBO/BCE: BE 0894.114.425

PHARMADRIES has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €263k and a net result of €74k. Equity is shrinking by ~19.2% per year across the filed fiscal years. Its solvency ranks better than 63% of 873 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.0% (low).

Watch Print / PDF

Checked score

Score 2024

80 / 100

Excellent▼ -13 vs 2023

The score combines four axes. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability100▲+21

Solvency55▼-43

Growth32▼-20

Stability100

Bankruptcy probability, 12 months

1.0% Low

0%0.5%1.5%4%10%≥ 25%

Credit up to €21k at 30 days acceptable

Liquidity ample (current ratio 1.59 against 5.02 in 2023), but 72.9% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 47

Relative position

BE, all sectors

reference

Sector 47

higher

← fewer bankruptcies more bankruptcies →

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

A punctual record breaks

This company filed 9 consecutive financial years on time. The year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.

NBB · 10 filings

Deviation from the deadline

2025

not confirmed

2024

28 d late

2023

65 d early

2022

70 d early

2021

34 d early

2020

45 d early

2019

42 d early

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

€74k▼ 7.8%

2023 · €80k

2022: €105k 2023: €80k

2022 → 2024

Working capital

€280k▼ 47.1%

2023 · €529k

2022: €448k 2023: €529k

2022 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line202220232024Trend

Equity€427k-€507k▲ 18.7%€263k▼ 48.2%

Operating result€149k-€113k▼ 23.9%€109k▼ 3.9%

Net result€105k-€80k▼ 23.9%€74k▼ 7.8%

Result per fiscal year

Operating resultNet result

The operating result has fallen two years in a row; 2024 is 4% below 2023 and is the lowest year so far.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €968k

22.2%

77.8%

Fixed assets €215k▼ 5.8%

Current assets €753k▲ 13.9%

Equity and liabilities €968k

27.1%

72.9%

Equity €263k▼ 48.2%

Debt €705k▲ 84.6%

The debt ratio rises from 43.0% to 72.9%: debt grows while equity shrinks.

Key figures and ratios

2024 value · change against 2023

EBITDA

€133k▼

2023 · €137k

Cash flow

€98k▼

2023 · €104k

Solvency

27.1%▼

2023 · 57.0%

Current ratio

1.59▼

2023 · 5.02

Quick ratio

1.28▼

2023 · 3.76

Debt / equity

2.69▲

2023 · 0.75

ROE

28.1%▲

2023 · 15.8%

ROA

7.6%▼

2023 · 9.0%

Interest coverage

14.23▼

2023 · 21.35

Debt

€705k▲

2023 · €382k

Debt ≤ 1 year

€473k▲

2023 · €132k

Debt > 1 year

€232k▼

2023 · €250k

Income taxes

€26k▼

2023 · €28k

Staff costs

€114k▲

2023 · €110k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Total assets 20/58€889k€968k▲

Fixed assets 21/28€228k€215k▼

Tangible fixed assets 22/27€228k€215k▼

Current assets 29/58€661k€753k▲

Stocks & contracts in progress 3€167k€148k▼

Amounts receivable within one year 40/41€313k€414k▲

Investments 50/53€2k€2k=

Cash & bank 54/58€179k€189k▲

Total equity & liabilities 10/49€889k€968k▲

Equity 10/15€507k€263k▼

Contributions / capital 10/11€120k€120k=

Reserves 13€127k€127k=

Accumulated profits (losses) 14€260k€16k▼

Amounts payable 17/49€382k€705k▲

Amounts payable after one year 17€250k€232k▼

Amounts payable within one year 42/48€132k€473k▲

Trade debts payable within one year 44€93k€116k▲

Income statement Code20232024

Gross operating margin 9900€248k€253k▲

Operating result 9901€113k€109k▼

Financial income 75€883€146▼

Financial charges 65€6k€9k▲

Result before taxes 9903€108k€100k▼

Income taxes 67/77€28k€26k▼

Net result for the period 9904€80k€74k▼

Result to be appropriated 9905€80k€74k▼

Timeline · acts, filings and financial milestones

All 12Financial 2Filings 10

2025

28-08

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 28 days late

2024

31-12

Financial Weakest financial yearnet €74k ▼7.8%

Net result drops to €74k, the lowest in the series.

27-05

NBB filing Annual accounts filed

fiscal year 2023 · full schema

2023

31-12

Financial Equity above €500kEq €507k ▲18.7%

2 profitable years in a row build equity to €507k.

22-05

NBB filing Annual accounts filed

fiscal year 2022 · full schema

2022

27-06

NBB filing Annual accounts filed

fiscal year 2021 · full schema

2021

16-06

NBB filing Annual accounts filed

fiscal year 2020 · full schema

2020

19-06

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2019

23-07

NBB filing Annual accounts filed

fiscal year 2018 · full schema

2018

13-06

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

23-06

NBB filing Annual accounts filed

fiscal year 2016 · full schema

2016

21-06

NBB filing Annual accounts filed

fiscal year 2015 · full schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

0 of 7 acts read

About the unread acts

We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Comparable companies · same sector, comparable size

Similar companies · same sector, comparable size

Kortenaken · Eq €265k

Ottignies-Louvain-la-Neuve · Eq €258k

GiGi

BE 0467.257.908

Dendermonde · Eq €252k

Of 2,067 companies in sector 47750 we hold annual accounts for 472. 299 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPublic limited company

Founded12-12-2007

Fiscal year end31-12

Activities, NACEBEL

47730Retail sale of pharmaceutical products

47750Retail sale of cosmetics and toilet articles

21100Manufacture of basic pharmaceutical products and pharmaceutical preparations

46150Agents in the wholesale of furniture, household goods and hardware

46460Wholesale of pharmaceutical and medical goods

47740Retail trade

47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses

Sources

Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 18-07-2026. Scores and ratios are computed by Checked and are not a credit decision.